Epinephrine Auto-Injectors Market Research, Analysis and Forecast 2022-2032

The Epinephrine Auto-Injectors Market Size is expected to reach US$ 2.54 Billion by 2032, up from USD 2 billion in 2022, at a 4.9% CAGR between 2022 and 2032.

In the epinephrine auto-injectors market future trends are expected to develop at a healthy rate. Syringes and injectors have developed significantly in response to evolving clinical and patient needs resulting in boosted demand for epinephrine auto-injector.

The epinephrine auto-injectors market opportunities are rapidly expanding. The rising prevalence of allergies among individuals has been a primary driver of epinephrine auto-injectors market growth. As a result, the growing number of people allergic to dust, insect bites and venom, food, and food additives has fueled epinephrine auto-injectors market growth.

Furthermore, vendor expenditures in R&D initiatives to produce chlorofluorocarbon-free epinephrine auto-injector inhalers employing hydrofluoroalkanes as propellant have expedited epinephrine auto-injectors market key trends and opportunities.

Adverse side effects of excessive epinephrine use, such as cardiac arrhythmia, pulmonary edoema, vomiting, brain haemorrhage, and might represent an epinephrine auto-injectors market issue.

The rising number of people suffering from various types of allergies, the availability of low-cost generic epinephrine auto-injectors, and the high rate of adoption of epinephrine auto-injectors in the United States are expected to drive the regional epinephrine auto-injector market during the forecast period along with the epinephrine auto-injector market adoption trends.

Competitive landscape:

New market research report on epinephrine auto-injectors says that Adamis Pharmaceuticals Corporation, Alk-Abello A/S, Impax Laboratories, Inc., Mylan N.V., Antares Pharma is among the legacy player’s vendors.

The research offers a comprehensive competition analysis of these top competitors in the epinephrine auto-injectors market, including epinephrine auto-injectors market growth, epinephrine auto-injectors market share, epinephrine auto-injectors market adoption trends and important market strategies.

Browse More@ https://www.futuremarketinsights.com/reports/epinephrine-auto-injectors-market

Key Segments:

By End-User:

  • Hospitals
  • Clinics
  • Home Based
  • Others

By Dosage:

  • 0.15 mg
  • 0.3 mg
  • Others

By Age Group:

  • 0-4 Years
  • 5-14 Years
  • 15-24 Years
  • 25-49 Years
  • 50-64 Years
  • Above 65 Years 

Comments

Post a Comment

Popular posts from this blog

Dental Imaging Equipment Market Will Generate Booming Growth Opportunities to 2030

Image
Future Market Insights’ recently published report on the  Dental Imaging Equipment Market  predicts that growth is expected to accelerate at a positive 7.9% CAGR during the forecast period of 2022-2030. The COVID-19 pandemic has reduced the number of patients with dental problems visiting healthcare settings due to mandatory enforcement of social distancing measures. Moreover, healthcare providers have reoriented their operations towards caring for COVID-19 positive patients. “Market players need to concentrate more on providing high resolution imaging in order to provide enhanced treatment. Techniques such as 3D-imaging, fluoroscopy and 4K ultra-HD will greatly augment market prospects for dental imaging equipment in the future,” opines an FMI analyst. Key Takeaways from FMI’s Dental Imaging Equipment Market Study Extraoral X-ray systems emerged as the kingpin in the dental imaging equipment market, accounting for ~30% of the revenue pie in 2019 ...
Read more

Neurointerventional Devices Market Latest Developments and Innovations Across the Industry

Image
According to a new report from Future Market Insights (FMI), the global Neurointerventional Devices Market will grow at a 4.7% CAGR through 2030. According to the study, the market will be worth $3.6 billion by the end of 2030. Data Points Market Insights Market Value 2021 US$ 2.4 Bn Market Value 2022 US$ 2.5 Bn Market Value 2030 US$ 3.6 Bn CAGR 2022-2030 4.7% Market Share of Top 5 Countries 72.5% Key Market Players Stryker Corporation, Penumbra Inc., Covidien Public Limited, Johnson & Johnson Private Limited and Terumo Corporation The prevalence of neurological disorders has more than tripled in recent years. According to the National Center for Biotechnology Information (NCBI), the prevalence of cerebral aneurysm is nearly 3.2%, with women being more likely than men over the age of 50. It is estimated that approxima...
Read more

Empowering Diabetics | A Comprehensive Analysis of the Continuous Glucose Monitoring Device Market

Image
According to Future Market Insights' recently released Continuous Glucose Monitoring Device Market Analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9% from 2023 to 2033. Market growth is predicted to be driven by an increase in the older population as well as a high prevalence of diabetes. The International Diabetes Federation predicts that the global diabetic population will reach 642 million by 2040. As a result, by 2040, one out of every 10 people would have diabetes, demonstrating the seriousness of the epidemic. Diabetes treatment and management are consequently projected to be a top priority for healthcare administrations and stakeholders around the world. Diabetes cases are predicted to increase, boosting market growth and the potential for continuous glucose monitoring systems, attracting and motivating various industry actors to prod...
Read more